HOME >> MEDICINE >> NEWS
Rising cost of cigarettes may help smokers honor new years resolution to quit

More than ever, a significant number of Americans resolved to ring in a smoke-free New Year when the clock struck midnight on December 31st. Leading economic researchers say this surge can be attributed to two key factors: cigarette price hikes and smoking ban legislation, which have taken hold in numerous states across the country.

"The data are clear. Higher cigarette prices, including those resulting from cigarette excise tax increases, have led to reductions in cigarette smoking," says Frank Chaloupka, Ph.D., director of the Health Policy Center and Professor of Economics at the University of Illinois at Chicago. "Our research finds that every 10 percent increase in cigarette prices reduces the number of people who smoke by approximately two percent; and that a permanent 10 percent increase in cigarette prices would reduce the average duration of smoking by about 10 percent."

Dr. Chaloupka, whose findings have been cited in anti-smoking ballot measures in a number of states, found that reductions in smoking resulting from higher cigarette taxes are furthered when states use the revenues to fund behavioral support programs to assist quitters. Moreover, investigators note that the recent cigarette price hikes have led to significant increases in the demand for stop smoking nicotine replacement therapies (NRT) such as the nicotine patch, gum and lozenge, which have been shown to significantly increase a smoker's chance of quitting successfully.

"Cold turkey has about a 95 percent chance of failure," says Steven Lamm, M.D., clinical assistant professor of medicine at New York University. "There are safe and effective FDA-approved products like the NicoDerm CQ nicotine patch, Nicorette gum and the new Commit lozenge that can help smokers control their cravings and withdrawal symptoms. These tools, combined with support and encouragement from friends and family, have been shown to increase a smoker's chances of quitting successfully."
'"/>

Contact: Kristin Zajaczkowski
kzajaczkowski@porternovelli.com
212-601-8201
Porter Novelli
8-Jan-2003


Page: 1 2

Related medicine news :

1. Rising young psychiatry researchers receive prestigious international award
2. Rising numbers of patients seeing non-physician clinicians, study finds
3. Rising ammonia emissions attributed to cars, not livestock
4. Tobacco-company-sponsored parties with free cigarettes may encourage students to start smoking
5. Majority of cigarettes in the US smoked by nicotine-dependent or psychiatrically ill persons
6. Activism prompts teen smokers to cut back on cigarettes, Stanford study finds
7. Heavy smokers see cigarettes as friends
8. Low tar cigarettes do not cut lung cancer risk
9. UNC study shows Internet offers youths easy way to buy cigarettes
10. Carcinogen in cigarettes causes mutation linked to lung cancer
11. Brain chemicals can thwart desire to smoke cigarettes

Post Your Comments:
(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... undergoing in vitro fertilization (IVF) are only about half as ... assisted reproduction technique, new research indicates, and the racial disparity ... study, about 31 percent of white patients became pregnant after ... Analyzing more than 4,000 IVF cycles over two years to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... to increased blood pressure, according to a new study. ... pressure for young adult women or for teenagers, according to ... or moderately, their risk of high blood pressure was cut ... in older adult men and women," said lead researcher Dr. ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , 20 de octubre de 2014  PneumRx, ... campo de la pulmonología intervencional, anunció hoy la ... casi 3 meses antes de lo programado. El Estudio ... de dispositivo de investigación (IDE) aprobada por la ... sistema de espiral de reducción de volumen pulmonar ...
(Date:10/20/2014)... 20, 2014  ResMed (NYSE: RMD ... Data Exchange program, a comprehensive suite of software ... and other health care providers. ... critical patient information. It integrates valuable sleep and ... patient management platforms with customers, in-house or third-party ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2
Cached News: